Patents by Inventor Kenneth Lewis Kees

Kenneth Lewis Kees has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Gonadotropin releasing hormone receptor antagonists
    Patent number: 7696210
    Abstract: Compounds of Formula I, useful as Gonadotropin Releasing Hormone (“GnRH”) (also known as Leutinizing Hormone Releasing Hormone) receptor antagonists, are disclosed.
    Type: Grant
    Filed: June 16, 2005
    Date of Patent: April 13, 2010
    Assignee: Wyeth
    Inventors: Lloyd Michael Garrick, Daniel Michael Green, Diane Barbara Hauze, Kenneth Lewis Kees, Joseph Theodore Lundquist, IV, Charles William Mann, John Francis Mehlmann, Jeffrey Claude Pelletier, John Francis Rogers, Jr., Jay Edward Wrobel
  • Acylresorcinol derivatives are selective vitronectin receptor inhibitors
    Publication number: 20030186967
    Abstract: Compounds of the formula 1
    Type: Application
    Filed: February 6, 2002
    Publication date: October 2, 2003
    Applicant: American Home Products Corporation
    Inventors: Kenneth Lewis Kees, Lloyd M. Garrick, Ariamala Gopalsamy
  • Bicyclic antagonists selective for the &agr;v&bgr;3 integrin
    Patent number: 6429214
    Abstract: This invention provides novel bicyclic compounds of Formula (I): wherein u, v, m, Y, G, A—B, R1, R1a, R2, R4, R5, R5a, and R5b are defined in the specification which compounds exhibit activity as inhibitors of bone resorption and compounds of Formula (II) wherein u, v, m, Y, G, D, A—B, R1, R1a, R2, R3, R4, R5, R5a, and R5b are defined in the specification which compounds exhibit activity as inhibitors of bone resorption.
    Type: Grant
    Filed: July 20, 2000
    Date of Patent: August 6, 2002
    Assignee: Wyeth
    Inventors: Arie Zask, Diane Barbara Hauze, Kenneth Lewis Kees, Richard Dale Coghlan, John Yardley
  • Unsaturated fatty acyl derivatives of 2-aminothiazoleacetic acid and their salts as inhibitors of phospholipase A.sub.2 derived from human sources
    Patent number: 5688821
    Abstract: This invention relates to compounds of the formula ##STR1## where R.sup.1 and R.sup.2 are both hydrogen or R.sup.1 and R.sup.2 form a bond;m=1 and n=3 and p=6,or m=3, 5 or 7 and n=1 and p=6,or m=4 and n=2 and p=6 or 8,and the E (trans) and Z (cis) isomers when R.sup.1 =R.sup.2 =H;and the basic addition salts thereof which are inhibitors of phospholipase A.sub.2 and are thus useful agents in the treatment of inflammatory diseases where arachidonic acid metabolic products are implicated, such as rheumatoid arthritis, inflammatory bowel diseases such as ulcerative colitis, atopic dermatitis conditions such as psoriasis and immediate hypersensitivity reactions such as allergic bronchial asthma and allergic rhinitis; and as gastric cytoprotective agents.
    Type: Grant
    Filed: December 20, 1996
    Date of Patent: November 18, 1997
    Assignee: American Home Products Corporation
    Inventor: Kenneth Lewis Kees